MedPath

YHR-1902

Generic Name
YHR-1902

Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2020-03-20
Last Posted Date
2020-05-26
Lead Sponsor
Yuhan Corporation
Target Recruit Count
30
Registration Number
NCT04316065
Locations
🇰🇷

Metro Hospital, Anyang-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath